(UMAC) Unusual Machines - Overview
Sector: Technology | Industry: Computer Hardware | Exchange: NYSE MKT (USA) | Market Cap: 802m USD | Total Return: 225.2% in 12m
Avg Turnover: 44.2M
Warnings
Share dilution 202.7% YoY
High Debt/EBITDA (9.5) with thin interest coverage (-26180.4)
Interest Coverage Ratio -26180.4 is critical
Beneish M-Score 1.00 > -1.5 - likely earnings manipulation
Altman Z'' -1.04 < 1.0 - financial distress zone
Choppy
Tailwinds
Rs Leader
Unusual Machines, Inc. (UMAC) is an American developer and distributor of small unmanned aircraft systems (sUAS) and drone components. Operating within the Electronic Components sector, the company utilizes a multi-channel sales strategy encompassing B2B contracts, direct-to-consumer e-commerce, and traditional retail outlets.
The company focuses on the integration of edge AI compute with flight control systems through a technical partnership with Lantronix Inc. This collaboration targets the growing demand for autonomous capabilities in drone hardware. The small drone market is currently characterized by a shift toward domestic manufacturing and Blue UAS compliance to meet heightened security standards for government and enterprise use.
Headquartered in Orlando, Florida, the firm rebranded from AerocarveUS Corporation in 2022 to reflect its broader commercial drone objectives. Investors tracking this sector may find further data on ValueRay useful for deeper fundamental analysis. As the industry moves toward automated flight, UMACs business model relies on the successful commercialization of proprietary AI-integrated components.
- Federal drone procurement bans on Chinese hardware drive domestic market share
- Development of AI-integrated flight controllers through Lantronix partnership impacts margins
- Consumer drone component demand fluctuates with e-commerce and retail sales volume
- Supply chain stability for essential drone components affects manufacturing production costs
- Regulatory shifts in autonomous drone operations influence commercial adoption and revenue
| Net Income: -5.64m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 142.7 > 1.0 |
| NWC/Revenue: 1.81k% < 20% (prev 89.54%; Δ 1.72k% < -1%) |
| CFO/TA -0.11 > 3% & CFO -37.4m > Net Income -5.64m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 128.2 > 1.5 & < 3 |
| Outstanding Shares: last quarter (48.1m) vs 12m ago 202.7% < -2% |
| Gross Margin: 34.77% > 18% (prev 0.26%; Δ 3.45k% > 0.5%) |
| Asset Turnover: 9.67% > 50% (prev 40.44%; Δ -30.78% > 0%) |
| Interest Coverage Ratio: -26.2k > 6 (EBITDA TTM -23.0m / Interest Expense TTM 887.0) |
| A: 0.92 (Total Current Assets 315.2m - Total Current Liabilities 2.46m) / Total Assets 339.7m |
| B: -0.13 (Retained Earnings -44.8m / Total Assets 339.7m) |
| C: -0.13 (EBIT TTM -23.2m / Avg Total Assets 178.5m) |
| D: -5.50 (Book Value of Equity -44.3m / Total Liabilities 8.07m) |
| Altman-Z'' = -1.04 = CCC |
| DSRI: 24.88 (Receivables 3.13m/51.0k, Revenue 17.3m/6.99m) |
| GMI: 0.76 (GM 34.77% / 26.31%) |
| AQI: 0.10 (AQ_t 0.05 / AQ_t-1 0.56) |
| SGI: 2.47 (Revenue 17.3m / 6.99m) |
| TATA: 0.09 (NI -5.64m - CFO -37.4m) / TA 339.7m) |
| Beneish M = 17.02 (Cap -4..+1) = D |
As of May 26, 2026, the stock is trading at USD 16.78 with a total of 6,924,100 shares traded.
Over the past week, the price has changed by +3.58%,
over one month by +13.23%,
over three months by +24.85% and
over the past year by +225.19%.
Unusual Machines has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy UMAC.
- StrongBuy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 25.3 | 51% |
P/E Forward = 222.2222
P/S = 46.4843
P/B = 2.4183
Revenue TTM = 17.3m USD
EBIT TTM = -23.2m USD
EBITDA TTM = -23.0m USD
Long Term Debt = 2.61m USD (estimated: total debt 3.33m - short term 714k)
Short Term Debt = 714k USD (from shortTermDebt, last quarter)
Debt = 3.33m USD (from shortLongTermDebtTotal, last quarter) (leases 3.33m already included)
Net Debt = -219.6m USD (calculated: Debt 3.33m - CCE 222.9m)
Enterprise Value = 582.4m USD (802.0m + Debt 3.33m - CCE 222.9m)
Interest Coverage Ratio = -26.2k (Ebit TTM -23.2m / Interest Expense TTM 887.0)
EV/FCF = 61.73x (Enterprise Value 582.4m / FCF TTM 9.43m)
FCF Yield = 1.62% (FCF TTM 9.43m / Enterprise Value 582.4m)
FCF Margin = 54.68% (FCF TTM 9.43m / Revenue TTM 17.3m)
Net Margin = -32.72% (Net Income TTM -5.64m / Revenue TTM 17.3m)
Gross Margin = 34.77% ((Revenue TTM 17.3m - Cost of Revenue TTM 11.3m) / Revenue TTM)
Gross Margin QoQ = 31.98% (prev 36.24%)
Tobins Q-Ratio = 1.71 (Enterprise Value 582.4m / Total Assets 339.7m)
Interest Expense / Debt = 0.03% (Interest Expense 887.0 / Debt 3.33m)
Taxrate = 0.0% (0.0 / 10.3m)
NOPAT = -23.2m (EBIT -23.2m * (1 - 0.00%)) [loss with tax shield]
Current Ratio = 79.50 (Total Current Assets 315.2m / Total Current Liabilities 3.96m)
Debt / Equity = 0.01 (Debt 3.33m / totalStockholderEquity, last quarter 331.6m)
Debt / EBITDA = 9.53 (negative EBITDA) (Net Debt -219.6m / EBITDA -23.0m)
Debt / FCF = -23.28 (Net Debt -219.6m / FCF TTM 9.43m)
Total Stockholder Equity = 166.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.16% (Net Income -5.64m / Total Assets 339.7m)
RoE = -2.68% (Net Income TTM -5.64m / Total Stockholder Equity 210.8m)
RoCE = -10.88% (EBIT -23.2m / Capital Employed (Equity 210.8m + L.T.Debt 2.61m))
RoIC = -6.87% (negative operating profit) (NOPAT -23.2m / Invested Capital 338.0m)
WACC = 14.98% (E(802.0m)/V(805.3m) * Re(15.04%) + D(3.33m)/V(805.3m) * Rd(0.03%) * (1-Tc(0.0)))
Discount Rate = 15.04% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 73.33 | Cagr: 109.8%
[DCF] Terminal Value 55.84% ; FCFF base≈9.43m ; Y1≈9.47m ; Y5≈10.0m
[DCF] Fair Price = 6.13 (EV 73.5m - Net Debt -219.6m = Equity 293.1m / Shares 47.8m; r=14.98% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.02 | # QB: 0
Revenue Correlation: -74.99 | Revenue CAGR: -73.40% | SUE: 2.96 | # QB: 1
EPS current Quarter (2026-06-30): EPS=-0.10 | Chg30d=N/A | Revisions=+20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=-0.10 | Chg30d=N/A | Revisions=+20% | Analysts=1
EPS current Year (2026-12-31): EPS=-0.35 | Chg30d=N/A | Revisions=+20% | GrowthEPS=-128.3% | GrowthRev=+226.9%
EPS next Year (2027-12-31): EPS=-0.20 | Chg30d=N/A | Revisions=N/A | GrowthEPS=+42.9% | GrowthRev=+45.9%